Neuronal NMDAR-TRPM4 “Death Complex” Disabled by Interface Inhibitors
Alzheimer’s and other forms of neurodegeneration may be prevented by small-molecule drugs of a new class, interface inhibitors that disrupt contact surfaces between receptors
Related Articles
Ten Companies to Watch in AI Drug Discovery
In AI-based drug discovery—a field benefiting from a cumulative investment of $60 billion—the leaders are making real progress toward approved therapies.
Insilico Details AI-Designed IBD Candidate’s Path to Nomination
ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting…
Tasca Raises $52 Million to Target Novel Lipid-Bound Protein Pocket in Cancer, Other Diseases
The company will develop a pipeline of small molecule inhibitors that target a unique lipid-binding pocket on proteins.
Insilico Details AI-Designed IBD Candidate’s Path to Nomination
ISM5411 is designed to directly regulate the intestinal immune microenvironment so that the drug simultaneously reduces the gut inflammation seen in IBD while also promoting…
Early Cancer Detection Boosted by Molecular Fingerprint
A new study reveals different types of cancer have unique molecular “fingerprints” which are detectable in early stages of the disease.
Gene Therapy Reverses Effects of Heart Failure and Restores Heart Function in Minipigs
Researchers suggest an application to FDA may be made within the next 12 months, requesting approval to carry out a human clinical trial with the…
Single Influenza Mutation Could Enable Human-to-Human Transmission
A single mutation in the surface protein of the highly pathogenic avian influenza (HPAI) H5N1 influenza virus could allow for easier human transmission.
How Electrical and Calcium Signaling Work as One to Regulate Blood Flow
A new study may reshape our understanding of blood flow regulation in the brain.
Weaving Textiles from Recombinant Spider Silk
Kraig Biocraft Laboratories has developed transgenic silkworms to produce spider silk in commercial quantities.
Patient Glioblastoma Response to CAR-T Cell Therapy Mirrored in Tumor-Derived Organoids in Real Time
Research shows that GBM organoids are a powerful, accurate tool for understanding what happens when treating a brain tumor using CAR-T cell therapy.